Supplemental Materials for:

Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
. These results demonstrated that the Foxp3-#32-bispecific mAb wasable to recognize and mediate T cell cytotoxicity against human Tregs in the context of HLA-A*02:01 molecules.
Supplemental Figure 4C . MAC-2A cells that have been transduced with GFP/luciferase was incubated with PBMCs from a HLA-A*02:01 negative donor at an E:T ratio 30:1, in the presence or absence of bispecific mAbs at 1ug/ml for total 3 days. Luciferin 30ug was added to each culture well before imaging. Total bioluminescence was measured in the indicated time points. Data represent average of three microwell cultures. . Possible cytotoxicity against normal hematopoietic cells by Foxp3-#32 bispecific mAb. PBMCs from HLA-A*02:01 positive or negative donors were incubated in the presence or absence of 0.2 or 1 ug/ml Foxp3-#32 bispecifc mAb or its isotype control overnight. Cells were washed and stained with mAbs to human CD3, CD19 and CD33 to determine whether these cell lineages are killed by the bispecific mAbs. The percentage of remaining cells in each cell lineage after co-culture is shown (upper two panels) In parallel, total PBMC numbers were counted by Trypan blue exclusion test (lower two panels). Data represent mean+/-SD from three HLA-A*02:01 positive and three HLA-A*02:01 negative donors (p values range from 0.3 to 0.6, for groups treated with Foxp3-#32 bispecific mAb or control, as compared to the untreated PBMC groups). In these experiments, as positive controls, MAC-1 cells were incubated with HLA-A*02:01 negative PBMCs as effectors at an E:T ratio of 30:1, in the presence or absence of bispecific mAbs at 1 ug/ml. Cells were harvested and stained with mAb to HLA-A2 (BB7.2 clone). Since only MAC1 cells are HLA-A2 positive, the reduction or disappearance of HLA-A2+ population indicates the killing of MAC-1. All MAC-1 cells were killed under these conditions. 
